A Randomized, Double-Blind, Placebo-Controlled Clinical

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab
StatusActive
Effective start/end date5/1/174/30/22

Funding

  • MERCK AND CO INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.